Enovis Corp (NYSE:ENOV) — Market Cap & Net Worth
Market Cap & Net Worth: Enovis Corp (ENOV)
Enovis Corp (NYSE:ENOV) has a market capitalization of $1.04 Billion ($1.04 Billion) as of September 21, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #8763 globally and #2499 in its home market, demonstrating a -2.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Enovis Corp's stock price $18.04 by its total outstanding shares 57669494 (57.67 Million). Also see how large is Enovis Corp's balance sheet for a full breakdown of the balance sheet.
Enovis Corp Market Cap History: 2015 to 2026
Enovis Corp's market capitalization history from 2015 to 2026. Data shows change from $2.32 Billion to $1.04 Billion (-8.38% CAGR). Also see ENOV cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Enovis Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.16% | #460 of 602 |
Weight: Enovis Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Enovis Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Enovis Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ENOV stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.68x
Enovis Corp's market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.56 Billion | $3.65 Billion | $128.11 Million | 0.98x | 27.82x |
| 2017 | $3.93 Billion | $3.30 Billion | $151.09 Million | 1.19x | 26.01x |
| 2018 | $2.07 Billion | $2.19 Billion | $140.20 Million | 0.95x | 14.79x |
| 2019 | $3.61 Billion | $3.33 Billion | -$527.65 Million | 1.08x | N/A |
| 2020 | $3.79 Billion | $3.07 Billion | $42.62 Million | 1.24x | 88.98x |
| 2021 | $4.56 Billion | $1.43 Billion | $71.66 Million | 3.20x | 63.63x |
| 2022 | $3.09 Billion | $1.56 Billion | -$13.29 Million | 1.97x | N/A |
| 2023 | $3.23 Billion | $1.71 Billion | -$33.26 Million | 1.89x | N/A |
| 2024 | $2.53 Billion | $2.11 Billion | -$825.49 Million | 1.20x | N/A |
| 2025 | $1.54 Billion | $2.25 Billion | -$1.18 Billion | 0.68x | N/A |
Competitor Companies of ENOV by Market Capitalization
Companies near Enovis Corp in the global market cap rankings as of September 21, 2026. Review how tangible is Enovis Corp's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Enovis Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Enovis Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Enovis Corp's market cap moved from $2.32 Billion to $ 1.04 Billion, with a yearly change of -8.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.04 Billion | -32.28% |
| 2025 | $1.54 Billion | -39.29% |
| 2024 | $2.53 Billion | -21.67% |
| 2023 | $3.23 Billion | +4.67% |
| 2022 | $3.09 Billion | -32.31% |
| 2021 | $4.56 Billion | +20.21% |
| 2020 | $3.79 Billion | +5.11% |
| 2019 | $3.61 Billion | +74.07% |
| 2018 | $2.07 Billion | -47.25% |
| 2017 | $3.93 Billion | +10.27% |
| 2016 | $3.56 Billion | +53.88% |
| 2015 | $2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Enovis Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.04 Billion USD |
| MoneyControl | $1.04 Billion USD |
| MarketWatch | $1.04 Billion USD |
| marketcap.company | $1.04 Billion USD |
| Reuters | $1.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Enovis Corp
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compres… Read more